- WHATS NEW?
- Suppression of chemokines by HDL
- HDL cholesterol linked to oestrogen levels
- New gene loci regulating HDL cholesterol identified
- Abnormal lipids when young predicts atherosclerosis in later life
- JUPITER: Is HDL cholesterol relevant to residual risk in low-risk patients on potent statin therapy?
- EAS Workshop: How does HDL protect against atherosclerosis?
Novel therapy increases HDL cholesterol
Administration of KC706, an oral p38 MAP kinase inhibitor, increases HDL cholesterol levels in patients with mixed dyslipidaemia.
Corporate sponsor
